carvacrol has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, X; Hua, C; Li, Z; Pan, X; Wu, W | 1 |
| Chen, J; He, J; Hua, F; Liu, CF; Pei, A; Qian, X; Xu, X; Yu, H; Zhang, ZL | 1 |
2 other study(ies) available for carvacrol and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Carvacrol Exerts Neuroprotective Effects Via Suppression of the Inflammatory Response in Middle Cerebral Artery Occlusion Rats.
Topics: Animals; Brain Ischemia; Cymenes; Infarction, Middle Cerebral Artery; Inflammation; Monoterpenes; Neuroprotective Agents; NF-kappa B; Rats; Reperfusion Injury; Signal Transduction | 2016 |
Carvacrol, a food-additive, provides neuroprotection on focal cerebral ischemia/reperfusion injury in mice.
Topics: Animals; Apoptosis; Brain Ischemia; Caspase 3; Chromones; Cymenes; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Food Additives; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Monoterpenes; Morpholines; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Signal Transduction | 2012 |